Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate

Nuclear Medicine Communications

Volumn 29, Issue 2, 2008, Pages 120-128

  Liu, Zhonglin ^a   Barrett, Harrison H ^a   Stevenson, Gail D ^a   Furenlid, Lars R ^b   Pak, Koon Yan ^b   Woolfenden, James M ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b MOLECULAR TARGETING TECHNOLOGIES INC   (United States)

Author keywords

Heart; Ischaemic preconditioning; Rat; Small animal SPECT

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; GLUCARATE TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMAGE PROCESSING; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; RADIOACTIVITY; RAT; REPERFUSION INJURY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CARDIOTONIC AGENTS; GLUCARIC ACID; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MODELS, STATISTICAL; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; REPERFUSION INJURY; RISK; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 37349106749     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282f29702     Document Type: Article

References (33)

1. Liu Z, Barrett HH, Stevenson GD, Kastis GA, Bettan M, Furenlid LR, et al. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischaemia with reperfusion. J Nucl Med 2004; 45:1251-1259.
2. Liu Z, Kastis GA, Stevenson GD, Barrett HH, Furenlid LR, Kupinski MA, et al. Quantitative analysis of acute myocardial infarct in rat hearts with ischaemia-reperfusion using a high-resolution stationary SPECT system. J Nucl Med 2002; 43:933-939.
3. Acton PD, Kung HF. Small animal imaging with high resolution single photon emission tomography. Nucl Med Biol 2003; 30:889-895.
4. Miyagawa M, Anton M, Haubner R, Simoes MV, Stadele C, Erhardt W, et al. PET of cardiac transgene expression: comparison of 2 approaches based on herpesviral thymidine kinase reporter gene. J Nucl Med 2004; 45:1917-1923.
5. 124I-FIAU in isolated perfused rat hearts after in vivo adenoviral transfer of herpes simplex virus type 1 thymidine kinase reporter gene. J Nucl Med 2005; 46:98-105.
6. Johnson G 3rd, Okada CC, Hocherman SD, Liu Z, Hart C, Khaw BA, et al. (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium. Eur J Nucl Med Mol Imaging 2006; 33:319-328.
7. 99mTc-glucarate. J Nucl Med 2004; 45:655-664.
8. Johnson LL, Schofield L, Mastrofrancesco P, Donahay T, Farb A, Khaw BA. Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. J Nucl Cardiol 2000; 7:590-598.
9. 99mTc-labeled glucarate. Circulation 1997; 95:1577-1584.
10. Khaw BA, Nakazawa A, O'Donnell SM, Pak KY, Narula J. Avidity of technetium-99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol 1997; 4:283-290.
11. Orlandi C, Crane PD, Edwards DS, Platts SH, Bernard L, Lazewatsky J, et al. Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. J Nucl Med 1991; 32:263-268.
12. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 1986; 74:1124-1136.
13. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991; 84:341-349.
14. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischaemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990; 66:1133-1142.
15. Wannenburg T, de Tombe PP, Little WC. Effect of adenosine on contractile state and oxygen consumption in isolated rat hearts. Am J Physiol 1994; 267:H1429-H1436.
16. Headrick JP. Ischaemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol 1996; 28:1227-1240.
17. Ballard-Croft C, Kristo G, Yoshimura Y, Reid E, Keith BJ, Mentzer RM Jr, et al. Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments. Am J Physiol Heart Circ Physiol 2005; 288:H1359-H1366.
18. Liu Y, Downey JM. Ischaemic preconditioning protects against infarction in rat heart. Am J Physiol 1992; 263:H1107-H1112.
19. Li Y, Kloner RA. Adenosine deaminase inhibition is not cardioprotective in the rat. Am Heart J 1993; 126:1293-1298.
20. Ganote CE, Armstrong SC. Adenosine and preconditioning in the rat heart. Cardiovasc Res 2000; 45:134-140.
21. de Jonge R, de Jong JW, Giacometti D, Bradamante S. Role of adenosine and glycogen in ischaemic preconditioning of rat hearts. Eur J Pharmacol 2001; 414:55-62.
22. Liem DA, van den Doel MA, de Zeeuw S, Verdouw PD, Duncker DJ. Role of adenosine in ischaemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors. Cardiovasc Res 2001; 51:701-708.
23. Li Y, Kloner RA. The cardioprotective effects of ischaemic ‘preconditioning’ are not mediated by adenosine receptors in rat hearts. Circulation 1993; 87:1642-1648.
24. Rowe RK, Aarsvold JN, Barrett HH, Chen JC, Klein WP, Moore BA, et al. A stationary hemispherical SPECT imager for three-dimensional brain imaging. J Nucl Med 1993; 34:474-480.
25. Verma S, Fedak PW, Weisel RD, Butany J, Rao V, Maitland A, et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002; 105:2332-2336.
26. Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 1999; 99:1972-1977.
27. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R. Demonstration of an early and a late phase of ischaemic preconditioning in mice. Am J Physiol 1998; 275:H1375-H1387.
28. Cohen MV, Baines CP, Downey JM. Ischaemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 2000; 62:79-109.
29. Vinten-Johansen J, Zhao ZQ, Corvera JS, Morris CD, Budde JM, Thourani VH, et al. Adenosine in myocardial protection in on-pump and off-pump cardiac surgery. Ann Thorac Surg 2003; 75:S691-S699.
30. Headrick JP, Hack B, Ashton KJ. Acute adenosinergic cardioprotection in ischaemic-reperfused hearts. Am J Physiol Heart Circ Physiol 2003; 285:H1797-H1818.
31. Vasara E, Katharou I, Lazou A. Myocardial adenosine does not correlate with the protection mediated by ischaemic or pharmacological preconditioning in rat heart. Clin Exp Pharmacol Physiol 2003; 30:350-356.
32. Peart JN, Gross GJ. Cardioprotection following adenosine kinase inhibition in rat hearts. Basic Res Cardiol 2005; 100:328-336.
33. Khaw BA, Silva JD, Petrov A, Hartner W. Indium-111 antimyosin and Tc-99m glucaric acid for noninvasive identification of oncotic and apoptotic myocardial necrosis. J Nucl Cardiol 2002; 9:471-481.